Skip to main content
. 2017 Apr 10;8(31):51331–51344. doi: 10.18632/oncotarget.17376

Figure 2. Forest Plot showing the results of meta-analyses of CD147 expression and survival.

Figure 2

(A) 1-year survival rate for CD 147 positive expression was worse. OR= 0.36, 95%CI= (0.20, 0.66), P= 0.0008. (B) 3-year survival rate for CD 147 positive expression was worse. OR= 0.39, 95%CI= (0.25, 0.60), P< 0.0001. (C) 5-year survival rate for CD 147 positive expression was worse. OR= 0.41, 95%CI= (0.28, 0.61), P< 0.00001. (D) 10-year survival rate for CD 147 positive expression was worse. OR= 0.39, 95%CI= (0.26, 0.57), P< 0.00001. (E) 15-year survival rate for CD 147 positive expression was worse. OR= 0.40, 95%CI= (0.28, 0.59), P< 0.00001. (F) 5-year HR for CD 147 positive expression was worse. HR= 1.61, 95%CI= (1.04, 2.49), P=0.015.